A percutaneous left ventricular assist device fails to offer improvement in 30-day outcomes compared with intra-aortic balloon pump (IABP) therapy in high-risk patients requiring hemodynamic support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results